The EICESS-92 trial is the largest trial in Ewing sarcoma to attempt to stratify therapy on the basis of another prognostic feature—tumor size.

Sarcomas are among the rarest and most enigmatic forms of cancer, accounting for just 1% of all adult cancer diagnoses ...

Jackson Kalbhenn has been cancer-free for almost a year and is now helping other young people who are facing the rare cancer known as Ewing Sarcoma.

Due to the relatively inferior long-term patient outcomes, we recognize the need for improving our understanding of pediatric sarcomas, specifically osteosarcoma, Ewing sarcoma and rhabdomyosarcoma.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...